image
Healthcare - Biotechnology - NASDAQ - IE
$ 31.42
-1.71 %
$ 5.18 B
Market Cap
14.76
P/E
Price Target Average
11.39%
Revenue Forecast Estimate
0.57%
EBIT Estimate
--19.65%
Net Income Estimate
--2.45%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Alkermes plc
image
Wall Street analysts predict an average 1-year price target for ALKS of $35 , with forecasts ranging from a low of $25 to a high of $40 .
ALKS Lowest Price Target Wall Street Target
25 USD -20.43%
ALKS Average Price Target Wall Street Target
35 USD 11.39%
ALKS Highest Price Target Wall Street Target
40 USD 27.31%
Price
Max Price Target
Min Price Target
Average Price Target
4040383836363434323230302828262624242222Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart ALKS

image
$1.8b$1.8b$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ALKS

image
$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ALKS

image
$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029